These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8516943)

  • 1. Mycophenolate mofetil and brequinar sodium: new immunosuppressive agents.
    Hullett DA; Sollinger HW
    Transplant Proc; 1993 Jun; 25(3 Suppl 2):45-7. PubMed ID: 8516943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolongation of allograft and xenograft survival with mycophenolate mofetil (RS-61443) and brequinar sodium (DUP-785).
    Hullett DA; Kawamura T; Fujino Y; Allison AM; Sollinger HW
    Transplant Proc; 1993 Feb; 25(1 Pt 1):700-1. PubMed ID: 8438444
    [No Abstract]   [Full Text] [Related]  

  • 3. The synergism of brequinar sodium and cyclosporine used in combination to prevent cardiac allograft rejection in the rat.
    Cosenza CA; Cramer DV; Eiras-Hreha G; Cajulis E; Wang HK; Makowka L
    Transplantation; 1993 Sep; 56(3):667-72. PubMed ID: 8212165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The development of Brequinar as an immunosuppressive drug for transplantation.
    Makowka L; Sher LS; Cramer DV
    Immunol Rev; 1993 Dec; 136():51-70. PubMed ID: 8132203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of allograft survival by combination RS-61443 and DUP-785 therapy.
    Kawamura T; Hullett DA; Suzuki Y; Bechstein WO; Allison AM; Sollinger HW
    Transplantation; 1993 Apr; 55(4):691-4; discussion 694-5. PubMed ID: 8475537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine gene expression in murine lymphocytes activated in the presence of FK 506, bredinin, mycophenolic acid, or brequinar sodium.
    Lemster B; Woo J; Strednak J; Wang SC; Todo S; Starzl TE; Thomson AW
    Transplant Proc; 1992 Dec; 24(6):2845-6. PubMed ID: 1281576
    [No Abstract]   [Full Text] [Related]  

  • 7. Brequinar sodium: monitoring immunosuppressive activity.
    Eiras-Hreha G; Cramer DV; Cosenza C; Chapman FA; Mills L; Cajulis E; Hill D; Jones E; Zajac I; Jaffee B
    Transplant Proc; 1993 Jun; 25(3 Suppl 2):32-6. PubMed ID: 8516940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prolongation of concordant hamster-to-rat cardiac xenografts by brequinar sodium.
    Cramer DV; Chapman FA; Jaffee BD; Zajac I; Hreha-Eiras G; Yasunaga C; Wu GD; Makowka L
    Transplantation; 1992 Sep; 54(3):403-8. PubMed ID: 1412717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunology in clinical practice. VI. Current immunosuppressive drugs].
    ten Berge RJ; Schellekens PT
    Ned Tijdschr Geneeskd; 1997 Nov; 141(47):2289-92. PubMed ID: 9550813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The current status of mycophenolate mofetil in pediatric renal transplantation.
    Tönshoff B
    Pediatr Transplant; 1999 Feb; 3(1):5-9. PubMed ID: 10359025
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunosuppressive activity of mycophenolate mofetil.
    Eugui EM; Allison AC
    Ann N Y Acad Sci; 1993 Jun; 685():309-29. PubMed ID: 8363235
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunosuppressive and other effects of mycophenolic acid and an ester prodrug, mycophenolate mofetil.
    Allison AC; Eugui EM
    Immunol Rev; 1993 Dec; 136():5-28. PubMed ID: 7907572
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevention of vascularized allograft and xenograft rejection in rodents by brequinar sodium.
    Cramer DV; Chapman FA; Makowka L
    Transplant Proc; 1993 Jun; 25(3 Suppl 2):23-8. PubMed ID: 8516938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DAB486-IL-2 (IL-2-toxin) in combination with low-dose RS-61443 (mycophenolate mofetil) prolongs murine thyroid allograft survival.
    Hullett DA; Landry AS; Eckhoff DE; Nichols JC; Eugui EM; Allison AC; Sollinger HW
    Transplant Proc; 1993 Feb; 25(1 Pt 1):756-7. PubMed ID: 8438470
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytidine potentiates the inhibitory effect of brequinar sodium on xeno-MLR, antibody production, and concordant hamster to rat cardiac xenograft survival.
    Woo J; Valdivia LA; Pan F; Celli S; Fung JJ; Thomson AW
    Ann N Y Acad Sci; 1993 Nov; 696():227-34. PubMed ID: 8109830
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro and in vivo mechanisms of action of the antiproliferative and immunosuppressive agent, brequinar sodium.
    Xu X; Williams JW; Shen J; Gong H; Yin DP; Blinder L; Elder RT; Sankary H; Finnegan A; Chong AS
    J Immunol; 1998 Jan; 160(2):846-53. PubMed ID: 9551920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of orthotopic liver allograft rejection in rats with a short-term brequinar sodium therapy. Analysis of intragraft cytokine gene expression.
    Shirwan H; Cosenza CA; Wang HK; Wu GD; Makowka L; Cramer DV
    Transplantation; 1994 Apr; 57(7):1072-80. PubMed ID: 8165706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel mechanisms of brequinar sodium immunosuppression on T cell activation.
    Forrest TL; Ware RE; Howard T; Jaffee BD; Denning SM
    Transplantation; 1994 Oct; 58(8):920-6. PubMed ID: 7940736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brequinar sodium potentiates the effects of cyclosporine in experimental small bowel transplantation.
    Collins BH; Areford ML; Fabian MA; Jaffee BD; Bollinger RR
    Transplant Proc; 1993 Jun; 25(3 Suppl 2):37-9. PubMed ID: 8516941
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of brequinar sodium on in vivo antibody production.
    Yasunaga C; Cramer DV; Cosenza CA; Tuso PJ; Chapman FA; Barnett M; Wu GD; Putnam BA; Makowka L
    Transplant Proc; 1993 Jun; 25(3 Suppl 2):40-4. PubMed ID: 8516942
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.